Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAOK3 | Q9H2K8 | 8/20 | 1.00 |
| ▸ | TAOK1 | Q7L7X3 | 12/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | DHODH | Q02127 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14422172 | 1.00 | TAOK3 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL5223796 | 0.90 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL31458362 | 0.90 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL31458158 | 0.88 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL5286330 | 0.88 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL31458377 | 0.87 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL14422171 | 0.87 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL31730316 | 0.87 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL31458364 | 0.83 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD | |
| SCHEMBL14422169 | 0.83 | TAOK1 (1.00) | TAOK3TAOK1ALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354151-A1 | INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2025-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250354151-A1 | INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE | TNNI3, TNNC1, TNNT2 | TAOK3 16/4885TAOK1 7/4885ALDH1A1 3769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.